Диссертация (1174300), страница 32
Текст из файла (страница 32)
– Ч. VI. – 143 с.13. Общая заболеваемость детского населения России (15 – 17 лет) в 2015году : статистические материалы / Г. А. Александрова [и др.] ; M-воздравоохранения Рос. Федерации, Департамент мониторинга, анализа и стратег.развития здравоохранения, ФГБУ «Центр. науч.-исследоват. ин-т орг.
иинформатизации здравоохранения». – М., 2016. – Ч. X. – 147 с.14. Реброва, О. Ю. Статистический анализ медицинских данных. Применениепакета прикладных программ STATISTICA / О. Ю. Реброва. ‒ М. : Изд-во МедиаСфера, 2006. ‒ 312 с.15. Российский адаптированный вариант опросников для оценки качестважизни и состояния здоровья детей с ювенильными хроническими артритами / Н. Н.Кузьмина [et al.] // Науч.-практ.
ревматология. – 2002. – № 1. – С. 40-44.16. Состояние специализированной ревматологической помощи детям и164взрослым в Российской Федерации. Проект Федеральной целевой программы«Ревматические болезни 2008-2012 гг.» (по материалам доклада на заседанииПрезидиума РАМН, 17 января 2007 г.) / А. А. Баранов [и др.] // Вопросысовременной педиатрии. – 2007. – Т. 6, № 1. – С. 6-8.17. Федоров, Е. С. Роль цитокиновой сети в регуляции воспаления приразличных вариантах ювенильного артрита / Е.
С. Федоров, С. О. Салугина, Н. Н.Кузьмина // Науч.-практ. ревматология. – 2009. – T. 47, № 3. – С. 74-89.18. Эволюция взглядов на терминологию и классификацию ювенильныххронических артритов / Н. Н. Кузьмина [и др.] // Науч.-практ. ревматология. ‒ 2001.‒ № 1. ‒ C. 41-45.19.
Ювенильный артрит: клинические рекомендации для педиатров. Детскаяревматология / Е. И. Алексеева [и др.] ; под ред. А. А. Баранова, Е. И. Алексеевой ;Науч. центр здоровья детей РАМН, Первый Московский гос. мед. ун-т им. И. М.Сеченова. – М. : ПедиатрЪ, 2013. – 120 с.20. 2011 American College of Rheumatology recommendations for the treatmentof juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents forthe treatment of arthritis and systemic features / T. Beukelman [et al.] // Arthritis CareRes (Hoboken). – 2011. – Vol.
63, № 4. – P. 465–482.21. A broad analysis of IL1 polymorphism and rheumatoid arthritis / A. K. Johnsen[et al.] // Arthritis Rheum. – 2008. – Vol. 58, № 7. – P. 1947-1957.22. A comprehensive meta-analysis of the association between three IL1Bpolymorphisms and rheumatoid arthritis / D. Dai [et al.] // Adv Biosci Biotechnol. – 2014.– Vol. 5, № 2.
– P. 108-116.23. A critical assessment of the factors affecting reporter gene assays for promoterSNP function: a reassessment of −308 TNF polymorphism function using a novelintegrated reporter system / M. Karimi [et al.] // Eur J Hum Genet. – 2009. – Vol. 17, №11. – P. 1454–1462.24. A Functional Polymorphism of Ptpn22 Is Associated with Type 1 Diabetes inthe BioBreeding Rat / J. Sarmiento [et al.] // J Immunol. – 2015.
– Vol. 194, № 2. – P.615-629.16525. A functional promoter haplotype of macrophage migration inhibitory factor islinked and associated with juvenile idiopathic arthritis / R. Donn [et al.] // ArthritisRheum. – 2004. – Vol. 50, № 5. – P. 1604-1610.26. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerativecolitis / M. E. Borm [et al.] // Int J Immunogenet. – 2005. – Vol.
32, № 6. – P. 401-405.27. A subgroup of juvenile idiopathic arthritis patients who respond well tomethotrexate are identified by the serum biomarker MRP8/14 protein / H. Moncrieffe [etal.] // Rheumatology (Oxford). – 2013. – Vol. 52, № 8. – P. 1467-1476.28. A tumour necrosis factor beta gene polymorphism in relation to monokinesecretion and insulin-dependent diabetes mellitus / F. Pociot [et al.] // Scand J Immunol.– 1991. – Vol. 33, № 1. – P.
37-49.29. ABCB1 and ABCC3 gene polymorphisms are associated with first-yearresponse to methotrexate in juvenile idiopathic arthritis / M. C. de Rotte [et al.] // JRheumatol. – 2012. – Vol. 39, № 10. – P. 2032-2040.30. Adams, A. Update on the pathogenesis and treatment of systemic onset juvenilerheumatoid arthritis / A. Adams, T. J. Lehman // Curr Opin Rheumatol. – 2005. – Vol.17. – P. 612-616.31. Aggarwal, B.
B. Historical perspectives on tumor necrosis factor and itssuperfamily: 25 years later, a golden journey / B. B. Aggarwal, S. C. Gupta, J. H. Kim// Blood. – 2012. – Vol. 119, № 3. – P. 651-665.32. Albarouni, M. Predictors of response to methotrexate in juvenile idiopathicarthritis [Электронный ресурс] / M. Albarouni, I. Becker, G. Horneff // PediatrRheumatol. – 2014. – Vol. 12. – ID 35. – URL: https://doi.org/10.1186/1546-0096-1235. (10.04.2017).33. Allele-specific quantification of tumor necrosis factor alpha (TNF)transcription and the role of promoter polymorphisms in rheumatoid arthritis patients andhealthy individuals / E.
L. Kaijzel [et al.] // Genes Immun. – 2001. – Vol. 2, № 3. – P.135-144.34. American College of Rheumatology provisional criteria for defining clinicalinactive disease in select categories of juvenile idiopathic arthritis / C. A. Wallace [et al.]166// Arthritis Care Res (Hoboken). – 2011. ‒ Vol. 63, № 7. – P. 929-936.35. Analysis of immunomodulatory activities of aqueous humor from eyes of micewith experimental autoimmune uveitis / K. Ohta [et al.] // J Immunol. – 2000.
– Vol. 164,№ 3. – P. 1185-1192.36. Analysis of the functional NFKB1 promoter polymorphism in rheumatoidarthritis and systemic lupus erythematosus / G. Orozco [et al.] // Tissue Antigens. – 2005.– Vol. 65, № 2. – P. 183-186.37. Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance totreatment / L. I. Sakkas [et al.] // Autoimmun Rev.
– 2014. – Vol. 13, № 11. – P. 11141120.38. Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoidarthritis onset in patients with undifferentiated arthritis: results from a 2-year prospectivestudy [Электронный ресурс] / N. Bizzaro [et al.] // Arthritis Res Ther. – 2013. – Vol.15, № 1. – R16. – URL: https://doi.org/10.1186/ar4148. (10.04.2017).39. Antiinflammatory and immunoregulatory action of methotrexate in thetreatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10gene expression demonstrated in vitro by competitive reverse transcriptase-polymerasechain reaction / A.
Constantin [et al.] // Arthritis Rheum. – 1998. – Vol. 41, № 1. – P. 4857.40. Antinuclear antibody-positive patients should be grouped as a separate categoryin the classification of juvenile idiopathic arthritis / A. Ravelli [et al.] // Arthritis Rheum.– 2011. – Vol. 63, № 1. – P. 267-275.41. Anti-TNF therapy for juvenile idiopathic arthritis-related uveitis / F. Semeraro[et al.] // Drug Des Devel Ther. – 2014.
– Vol. 8. – P. 341-348.42. Anti-TNF Treatment Response in Rheumatoid Arthritis Patients Is Associatedwith Genetic Variation in the NLRP3-Inflammasome [Электронный ресурс] / J. Sode[et al.] // PLoS ONE. – 2014. – Vol. 9, № 6. – e100361. – URL:https://doi.org/10.1371/journal.pone.0100361. (10.04.2017).43. Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associatedwith joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA)167[Электронный ресурс] / L. Berntson [et al.] // Pediatr Rheumatol. ‒ 2014. ‒ Vol. 12.
‒ID 22. – URL: https://doi.org/10.1186/1546-0096-12-22. (10.04.2017).44. Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis / M.Santos Lacomba [et al.] // Ophthalmic Res. – 2001. – Vol. 33, № 5. – P. 251-255.45. Asadullah, K. Interleukin-10 Therapy ‒ Review of a New Approach / K.Asadullah, W. Sterry, H. D. Volk // Pharmacol Rev. – 2003. – Vol. 55, № 2. – P. 241269.46. Assier, E. Interleukin-6: from identification of the cytokine to development oftargeted treatments / E. Assier, M. C. Boissier, J.
M. Dayer // Joint Bone Spine. – 2010.– Vol. 77, № 6. – P. 532-536.47. Association analysis of the 1858C>T polymorphism in the PTPN22 gene injuvenile idiopathic arthritis and other autoimmune diseases / M. K. Viken [et al.] // GenesImmun. – 2005. – Vol. 6, № 3. – P. 271–273.48. Association between Interleukin-6 Gene Polymorphisms and RheumatoidArthritis in Chinese Han Population: A Case-Control Study and A Meta-analysis / F. Li[et al.] // Sci Rep. – 2014. – Vol. 4. – ID 5714.49.
Association between PTPN22 C1858T polymorphism and alopecia areata risk/ M. Salinas-Santander [et al.] // Exp Ther Med. – 2015. – Vol. 10, № 5. – P. 1953-1958.50. Association between serum inflammatory cytokines and disease activity injuvenile idiopathic arthritis / L. S. Ou [et al.] // Clin Rheumatol. – 2002. – Vol. 21, № 1.– P. 52-56.51. Association between the PTPN22 gene and rheumatoid arthritis and juvenileidiopathic arthritis in a UK population: Further support that PTPN22 is an autoimmunitygene / A. Hinks [et al.] // Arthritis Rheum. – 2005. – Vol. 52, № 6.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
